Drug development has transformed immeasurably over the past decade. Manufacturing costs have risen, particularly for biologics (incl. CGT) and personalized medicines. In addition, the availability of comparator drug products has become less certain, making traditional packaging approaches not the most suitable for current clinical trial requirements.
In response, contract manufacturing organizations (CMOs) are increasingly offering alternatives to traditional drug packaging including Lean methodologies and Just in Time (JIT). This session will delve into the suite of flexible packaging capabilities available to meet the needs of the market and explore hybrid models combining traditional and innovative packaging approaches – within the same Study and even at the same time.
Date: Wednesday, 29 April 2026
Time: 8:30 – 11:00
Venue: Medicon Village, Auditorium, Building Inspira, Scheelevägen 4, Lund, Sweden
Program
| 8:30 | Networking, registration and light breakfast |
| 9:00 | Welcome and introduction to Medicon Valley Alliance David Munis Zepernick, Director, Member Engagement & Communication, Medicon Valley Alliance |
| 9:05 | Welcome and introduction to Almac Mark Daly – Senior Business Development Manager |
| 9:15 | An overview of JTL (Just in Time Labelling) and JTM (Just-in-Time Manufacturing) Lyn McNeil – Group Manager Supply Chain Solutions The differences, the benefits and how embracing a hybrid packaging solution could expand your clinical trial footprint Lyn McNeil – Group Manager Supply Chain Solutions |
| 10:00 | Q&A |
| 10:15 | Networking |
| 11:00 | End of Good Morning Meeting |
Speakers
 |
Lyn McNeill is the Group Manager for the Supply Chain Solutions Team at Almac Clinical Services. Based in Northern Ireland, her Global Team is responsible for the strategic development and commercialization of Almac’s supply chain service portfolio, including Direct to Patient, Almac Adapt ™ (Just-in-Time Manufacturing), and Supply Chain Management services. |
 |
Mark Daly is Senior Business Development Manager at Almac. He is responsible for sponsors operating in both Scandinavia and Ireland. With an acute business insight, Mark makes it his mission to fully immerse himself in his customers’ projects and objectives before tailoring bespoke clinical supply solutions that meet their varied requirements.
|
| Organized by | In collaboration with |
 |
 |